PIONEERING MICRO-DOSE BRAND ZENO LAUNCHES AT CALIFORNIA’S LARGEST INDEPENDENT CANNABIS RETAILER, SWEET FLOWER
October 19, 2021 11:00 ET | Zeno
Los Angeles, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Zeno — the groundbreaking micro-dose brand that launched online-only as a direct-to-consumer cannabis product — will become available at...
KemPharm Logo
KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market
October 19, 2021 07:30 ET | KemPharm
Trading to commence effective with the open of business on October 19, 2021 CELEBRATION, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company...
pE7QWYd0.png
Digital Mental Healthcare Provider Ahead Launches New Medication Management Service and Expands Provider Network
September 14, 2021 09:00 ET | Ahead
SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ahead, the fast-growing tech-enabled mental healthcare platform, today announced the launch of a new medication management service. With a...
Screen Shot 2020-07-28 at 11.27.29 AM.png
ABVC BioPharma Completes Site Selection for ABV-1505 ADHD Phase II Part 2 Clinical Study
September 13, 2021 08:30 ET | ABVC BioPharma, Inc.
Completion of the Study Expected by the End of 2022 FREMONT, CA, Sept. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
logo.jpg
Vallon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 10, 2021 08:05 ET | Vallon Pharmaceuticals Inc.
- Company continues to drive enrollment in pivotal intranasal abuse study evaluating ADAIR toward completion before year-end 2021 - ADAIR targeting the large and growing Adderall® segment of the...
INTRODUCING ZENO: THE FIRST TRUE THC MICRO-DOSE PRODUCT FOR DAILY USE
August 09, 2021 10:00 ET | Zeno
Los Angeles, CA, Aug. 09, 2021 (GLOBE NEWSWIRE) -- At 0.4mg of THC per tablet, Zeno is the first true micro-dose cannabis product on the California market, balanced with L-Theanine to offer...
KemPharm Logo
KemPharm to Report Second Quarter 2021 Results
August 05, 2021 07:30 ET | KemPharm
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, August 12, 2021, 4:30 p.m. ET CELEBRATION, Fla., Aug. 05, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:...
Praxis Bioresearch Announces Positive Results from Clinical Microdose Study in Humans Showing Oral Activation of Its Novel Prodrug Stimulant PRX-P4-003
June 23, 2021 06:07 ET | Praxis Bioresearch, LLC
All subjects who were dosed with Prodrug PRX-P4-003 had systemic exposure of the active moiety (-)-fencamfamine suggesting robust intestinal conversionAs anticipated, fed subjects showed earlier...
OWP_Logo_Primary.png
OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
April 22, 2021 08:00 ET | OWP Pharmaceuticals
NAPERVILLE, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
logo.jpg
Vallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential Approval
April 13, 2021 08:05 ET | Vallon Pharmaceuticals Inc.
- Ongoing ADAIR SEAL study on target for pivotal data readout in second half of 2021- Target NDA filing in Q2 2022 for a potential abuse-deterrent alternative to commercially available IR amphetamines...